×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Oncostream member and receive full access to its content!
You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.
Registration Login
Registration Login
Contexte :
Après plusieurs décennies sans avancées majeures, de nouvelles molécules viennent redéfinir la prise en charge des cancers de l’endomètre.
Deux experts vous partagent leur analyse des données actuelles et des dernières recommandations à travers des cas cliniques.
Experts :
Pr Jean-Sébastien Frenel - Oncologue médical, Institut de Cancérologie de l’Ouest, Saint-Herblain
Pr Isabelle Ray-Coquard - Oncologue médical, Centre Léon Bérard, Lyon
Programme :
- Présentation des recommandations de Saint Paul de Vence 2025 dans les cancers de l’endomètre avancé ou en rechute
Pr Jean Sébastien Frenel
- Cas clinique 1 : Prise en charge des tumeurs dMMR
Pr Isabelle Ray-Coquard
- Cas clinique 2 : Prise en charge des tumeurs pMMR
Pr Jean Sébastien Frenel
- Débat/Discussion & Réponses aux questions
Shooting date : 2025-06-11
Last update : 2025-06-12
Last update : 2025-06-12
Suggestions
Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)
San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)
Prise en charge des cancers de l'ovaire en rechute :
état des lieux et perspectives
Share
Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)
PARPi dans le cancer de l'ovaire en 1L
Données actuelles et perspectives pour la combinaison avec l’IO
Share
Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Monday, September 25th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)
San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)
Les scores indispensables dans la prise en charge des cancers de l'ovaire
Cycle d'enseignement - Les cancers gynécologiques
Share
Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, March 14th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)
Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?
Cycle d'enseignement sur le cancer de l'ovaire - Troisième session
Share